Skip to main content
. 2014 Dec 14;4:75. doi: 10.1186/s13550-014-0075-x

Table 1.

Organ biodistribution of IG3

Control 2 W-MI 4 W-MI
MI infarct (apex) 0.058 ± 0.039 0.151 ± 0.047 0.071 ± 0.059
MI border 0.047 ± 0.028 0.110 ± 0.021* 0.056 ± 0.044
MI remote 0.045 ± 0.033 0.108 ± 0.026* 0.055 ± 0.044
Lung 0.094 ± 0.034 0.194 ± 0.055 0.093 ± 0.073
Liver 0.236 ± 0.249 0.519 ± 0.095 0.192 ± 0.198
Spleen 0.079 ± 0.035 0.356 ± 0.041Φ 0.134 ± 0.118
Kidney 0.502 ± 0.101 0.784 ± 0.149 0.693 ± 0.367
Bone 0.057 ± 0.025 0.070 ± 0.013 0.053 ± 0.034
Thyroid 1.126 ± 1.409 1.326 ± 0.298 1.342 ± 0.223
Muscle 0.015 ± 0.004 0.021 ± 0.001 0.022 ± 0.013

Data are presented as %ID/g (mean ± SD) 4 h after injection.

%ID/g, percent injected dose per gram; MI, myocardial infarction; 2 W-MI, myocardial infarction 2 weeks old; 4 W-MI, myocardial infarction 4 weeks old.

*p < 0.05 control vs. 2 W-MI rats.

p < 0.01 control vs. 2 W-MI rats.

Φ p = 0.0571 2 W-MI vs. control and 2 W-MI vs. 4 W-MI rats.